AR101088A1 -
BIOLOGICAL CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT DERIVED FROM GLATIRAMER ACETATE BY HUMAN AND NON-HUMAN MAMMAL CELLS
- Google Patents
BIOLOGICAL CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT DERIVED FROM GLATIRAMER ACETATE BY HUMAN AND NON-HUMAN MAMMAL CELLS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva PharmafiledCriticalTeva Pharma
Publication of AR101088A1publicationCriticalpatent/AR101088A1/en
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
La presente provee un proceso de caracterización de una sustancia o producto farmacológico relacionado con acetato de glatiramer que comprende los pasos de: a) obtener un lote de la sustancia o producto farmacológico relacionado con acetato de glatiramer; b) poner en contacto células de mamífero con una cantidad de la sustancia o producto farmacológico relacionado con acetato de glatiramer del paso a), y c) i) determinar el nivel de expresión de al menos un gen según se indica en la memoria descriptiva, caracterizando así la sustancia o producto farmacológico relacionado con acetato de glatiramer del paso a). Producto farmacológico.This provides a process for characterizing a drug substance or product related to glatiramer acetate comprising the steps of: a) obtaining a batch of the drug substance or product related to glatiramer acetate; b) contacting mammalian cells with an amount of the substance or drug product related to glatiramer acetate from step a), and c) i) determining the level of expression of at least one gene as indicated in the specification, characterizing thus the substance or drug product related to glatiramer acetate from step a). Pharmacological product
ARP150102116A2014-07-012015-07-01
BIOLOGICAL CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT DERIVED FROM GLATIRAMER ACETATE BY HUMAN AND NON-HUMAN MAMMAL CELLS
AR101088A1
(en)
computer-implemented method for inferring the activity of a tgf-b cell signaling pathway in an individual; apparatus for inferring the activity of a tgf-b cellular signaling pathway in an individual; non-transient storage medium; computer program; kits for measuring expression levels of three or more tgf-b cell signaling pathway target genes in a sample from an individual; infer the activity of a tgf-b cell signaling pathway in an individual; infer the activity of a tgf-b cell signaling pathway in an individual; and use of the kit
Anti-cancer adjuvant composition containing rip3 promoter expression as an active ingredient, method for selecting anti-cancer adjuvant composition to improve the sensitivity of anti-cancer drug, promoting rip3 expression, and method for monitoring sensitivity; cancer medicine